Value assessment of PD-1/PD-L1 inhibitors in the treatment of oesophageal and gastrointestinal cancers

Overview of attention for article published in Frontiers in Pharmacology, April 2023

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter: 4 X users

Readers on

mendeley: 7 Mendeley

Summary X

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 6,938 followers.

Value assessment of PD-1/PD-L1 inhibitors in the treatment of oesophageal and gastrointestinal cancers https://t.co/NdfQPefQ81 https://t.co/CQveks5iA2

08 May 2023

Reply Repost Favourite

RT @FrontPharmacol: New Research: Value assessment of PD-1/PD-L1 inhibitors in the treatment of oesophageal and gastrointestinal cancers ht…

21 Apr 2023

Reply Repost Favourite

RT @FrontPharmacol: New Research: Value assessment of PD-1/PD-L1 inhibitors in the treatment of oesophageal and gastrointestinal cancers ht…

21 Apr 2023

Reply Repost Favourite

New Research: Value assessment of PD-1/PD-L1 inhibitors in the treatment of oesophageal and gastrointestinal cancers https://t.co/tK9kyT2cay #pharmacology

21 Apr 2023

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.